Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic

Alessandro Allegra1, Mario Di Gioacchino2,3, Alessandro Tonacci4

  • 1Division of Hematology, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, 98125 Messina, Italy.

Cells
|November 27, 2021
PubMed

Insights

Exosomes, small vesicles, play a crucial role in multiple myeloma (MM) progression by creating a pro-tumoral environment. Targeting these exosomes offers a promising therapeutic strategy for this incurable hematological disease.

Area of Science:

  • Hematology
  • Cell Biology
  • Cancer Research

Background:

  • Multiple myeloma (MM) is an incurable hematological malignancy.
  • The bone marrow microenvironment supports MM plasma cell growth and survival.
  • Exosomes, nanoscale vesicles, are implicated in MM pathogenesis and progression.

Purpose of the Study:

  • To review the role of exosomes in the progression of monoclonal gammopathies.
  • To analyze the impact of exosomes on neoplastic plasma cell proliferation.
  • To discuss exosomes as potential therapeutic targets for MM.

Main Methods:

  • Literature review of studies on exosomes in multiple myeloma.
  • Analysis of exosome content (proteins, lipids, nucleic acids) and function.
  • Examination of exosome-mediated cell-cell interactions in the bone marrow milieu.

Main Results:

  • Exosomes facilitate MM progression by regulating interactions between MM cells and the microenvironment.
  • Mesenchymal stem cell-derived exosomes confer chemoresistance to MM cells.
  • MM cell-derived exosomes promote angiogenesis, immune evasion, and bone lesions.

Conclusions:

  • Exosomes are key mediators in the pathogenesis and progression of multiple myeloma.
  • Understanding exosome function provides insights into MM development.
  • Targeting exosomes presents a potential novel therapeutic avenue for MM patients.